Walker M
Br J Pharmacol. 2006; 147 Suppl 1:S222-31.
PMID: 16402108
PMC: 1760742.
DOI: 10.1038/sj.bjp.0706500.
Chen M, Hashizume H, Abiko Y
Br J Pharmacol. 1996; 118(4):865-70.
PMID: 8799555
PMC: 1909535.
DOI: 10.1111/j.1476-5381.1996.tb15479.x.
Millar J, VAUGHAN WILLIAMS E
Br J Pharmacol. 1982; 75(1):109-21.
PMID: 7074278
PMC: 2071450.
DOI: 10.1111/j.1476-5381.1982.tb08763.x.
Millar J, VAUGHAN WILLIAMS E
Br J Pharmacol. 1982; 75(3):469-78.
PMID: 7066601
PMC: 2071575.
DOI: 10.1111/j.1476-5381.1982.tb09163.x.
Downes H, Taylor S
Br J Pharmacol. 1983; 78(2):339-51.
PMID: 6131719
PMC: 2044705.
DOI: 10.1111/j.1476-5381.1983.tb09399.x.
The role of the local anaesthetic properties of beta-adrenoceptor blocking agents in antagonizing CaCl2-induced arrhythmias in the rat.
Evangelista S, Maggi C, Meli A
Br J Pharmacol. 1981; 73(3):725-7.
PMID: 6113866
PMC: 2071696.
DOI: 10.1111/j.1476-5381.1981.tb16808.x.
The effect of altered thyroid state on atrial intracellular potentials.
FREEDBERG A, Papp J, Williams E
J Physiol. 1970; 207(2):357-69.
PMID: 5499024
PMC: 1348711.
DOI: 10.1113/jphysiol.1970.sp009066.
The effect of propranolol on the human and canine transmembrane action potential.
Coltart D, Meldrum S, Hamer J
Br J Pharmacol. 1970; 40(1):148P-149P.
PMID: 5487010
PMC: 1702656.
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.
Singh B, VAUGHAN WILLIAMS E
Br J Pharmacol. 1970; 39(4):675-87.
PMID: 5485144
PMC: 1702723.
DOI: 10.1111/j.1476-5381.1970.tb09893.x.
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.
Singh B, VAUGHAN WILLIAMS E
Br J Pharmacol. 1970; 39(4):657-67.
PMID: 5485142
PMC: 1702721.
DOI: 10.1111/j.1476-5381.1970.tb09891.x.
The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity.
Papp J, VAUGHAN WILLIAMS E
Br J Pharmacol. 1969; 37(2):380-90.
PMID: 5348427
PMC: 1703703.
Plasma propranolol levels associated with suppression of ventricular ectopic beats.
Coltart D, Gibson D, SHAND D
Br Med J. 1971; 1(5747):490-1.
PMID: 5101356
PMC: 1795199.
DOI: 10.1136/bmj.1.5747.490.
Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173.
Singh B, VAUGHAN WILLIAMS E
Br J Pharmacol. 1972; 44(1):1-9.
PMID: 5015038
PMC: 1665694.
DOI: 10.1111/j.1476-5381.1972.tb07232.x.
A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
Basil B, Jordan R, Loveless A, Maxwell D
Br J Pharmacol. 1974; 50(3):323-33.
PMID: 4850183
PMC: 1776679.
DOI: 10.1111/j.1476-5381.1974.tb09607.x.
Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
Singh B, Williams E
Br J Pharmacol. 1971; 43(1):10-22.
PMID: 4400181
PMC: 1665935.
DOI: 10.1111/j.1476-5381.1971.tb07152.x.
Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle.
Singh B, Williams E
Br J Pharmacol. 1970; 38(4):749-57.
PMID: 4392560
PMC: 1702589.
DOI: 10.1111/j.1476-5381.1970.tb09884.x.
The action of beta-receptor antagonists on intracellular cardiac potentials.
Shevde S, Spilker B
Br J Pharmacol. 1970; 38(2):448P.
PMID: 4392104
PMC: 1702798.
A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
Papp J, Williams E
Br J Pharmacol. 1969; 37(2):391-9.
PMID: 4390670
PMC: 1703656.
DOI: 10.1111/j.1476-5381.1969.tb10576.x.
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Singh B, Jewitt D
Drugs. 1974; 7(6):426-61.
PMID: 4153572
DOI: 10.2165/00003495-197407060-00004.
The inhibition by beta-adrenoceptor blocking agents of calcium uptake into and efflux from isolated sarcoplasmic vesicles.
TEMPLE D, Hasselbach W, MAKINOSE M
Naunyn Schmiedebergs Arch Pharmacol. 1974; 282(2):187-94.
PMID: 4153127
DOI: 10.1007/BF00499033.